All Business Industries
Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022
EX-10.16 5 ex1016-calsadasalaryupdate.htm EX-10.16 Document
Cris Calsada Yearly Discretionary Base Salary Increase
The Board of Directors (the “Board”) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Ms. Calsada’s annual base salary to $340,725, effective January 1, 2022.